Effect of total isoflavones from pueraria lobata on the expressions of preproenkephalin, prodynorphin and D2 dopamine receptor mRNA in PC12 cells induced by MPP+

详细信息    查看全文

• 作者：Miaoxian Dong (1)
  Chengchong Li (1)
  Yutao Gen (1)
  Chun Zhang (1)
  Xiaoming Li (1)
  Yingcai Niu (1) (2)
  
• 关键词：Parkinson’s disease (PD) ; total isoflavones from pueraria lobata (TIP) ; preproenkephalin ; D2 dopamine receptor ; prodynorphin ; 1 ; methyl ; 4 ; phenylpyridinium ion (MPP+)
• 刊名：The Chinese-German Journal of Clinical Oncology
• 出版年：2010
• 出版时间：January 2010
• 年：2010
• 卷：9
• 期：1
• 页码：48-52
• 全文大小：176KB
• 参考文献：1. Haik KL, Shear DA, Hargrove C, / et al. 7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson’s disease. Exp Clin Psychopharmacol, 2008, 16: 178-89. CrossRef
  2. Ritz B, Ascherio A, Checkoway H, / et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol, 2007, 64: 990-97. CrossRef
  3. Whitehill TL, Wong LL. Effect of intensive voice treatment on tone-language speakers with Parkinson’s disease. Clin Linguist Phon, 2007, 21: 919-25. CrossRef
  4. Rocca WA, Bower JH, Maraganore DM, / et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology, 2008, 70: 200-09. CrossRef
  5. Kuan WL, Lin R, Tyers P, / et al. The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias. Neurobiol Dis, 2007, 25: 594-08. CrossRef
  6. Cheng Y, He G, Mu X, / et al. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett, 2008, 441: 16-0. CrossRef
  7. Wang X, Liang XB, Li FQ, / et al. Therapeutic strategies for Parkinson’s disease: the ancient meets the future -traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res, 2008, 33: 1956-963. CrossRef
  8. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta Ct) method. Methods, 2001, 25: 402-08. CrossRef
  9. Fernandez HH, Lapane KL, Ott BR, / et al. Gender differences in the frequency and treatment of behavior problems in Parkinson’s disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. Mov Disord, 2000, 15: 490-96. CrossRef
  10. Brighina L, Okubadejo NU, Schneider NK, / et al. Beta-synuclein gene variants and Parkinson’s disease: a preliminary case-control study. Neurosci Lett, 2007, 420: 229-34. CrossRef
  11. Khealani BA, Baig SM. Clinical spectrum of Parkinson’s disease from Pakistan. Singapore Med J, 2006, 47: 1075-079.
  12. Ragonese P, D’Amelio M, Savettieri G. Implications for estrogens in Parkinson’s disease: an epidemiological approach. Ann NY Acad Sci, 2006, 1089: 373-82. CrossRef
  13. González C, Díaz F, Alonso A. Neuroprotective effects of estrogens: cross-talk between estrogen and intracellular insulin signalling. Infect Disord Drug Targets, 2008, 8: 65-7.
  14. Xu K, Xu Y, Brown-Jermyn D, / et al. Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. J Neurosci, 2006, 26: 535-41. CrossRef
  15. Gélinas S, Martinoli MG. Neuroprotective effect of estradiol and phytoestrogens on MPP⁺-induced cytotoxicity in neuronal PC12 cells. J Neurosci Res, 2002, 70: 90-6. CrossRef
  16. Collier TJ, Steece-Collier K, McGuire S, / et al. Cellular models to study dopaminergic injury responses. Ann NY Acad Sci, 2003, 991: 140-51. CrossRef
  17. Qian JJ, Cheng YB, Yang YP, / et al. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP⁺-induced neurotoxicity in PC12 cells. Neurosci Lett, 2008, 435: 142-46. CrossRef
  18. Anantharam V, Kaul S, Song C, / et al. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP⁺)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology, 2007, 28: 988-97. CrossRef
  19. Tsuchiya M, Miura T, Hanaoka T, / et al. Effect of soy isoflavones on endometriosis: interaction with estrogen receptor 2 gene polymorphism. Epidemiology, 2007, 18: 402-08. CrossRef
  20. Liu LX, Chen WF, Xie JX, / et al. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson’s disease. Neurosci Res, 2008, 60: 156-61. CrossRef
  21. Song SZ, Dong ZN, Gu F, / et al. Studies of bi-derectional modulation effect of kudzuvine root on immunol cells. Chin J Chin Mat Med (Chinese), 2002, 27: 684-87.
  22. Pan HP, Li G. Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia- reperfusion injury. Yakugaku Zasshi, 2008, 128: 1689-698. CrossRef
  23. Damier P, Hirsch EC, Agid Y, / et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain, 1999, 122: 1401-402. CrossRef
  24. Wirkner K, Krause T, K?les L, / et al. D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of Nmethyl-d-aspartate currents in the rat prefrontal cortex. Neurosci Lett, 2004, 372: 89-3. CrossRef
  25. Gruber SH, Nomikos GG, Mathé AA. d-Amphetamine-induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors. J Neurosci Res, 2002, 69: 133-39. CrossRef
  26. Dourmap N, Costentin J. Involvement of glutamate receptors in the striatal enkephalin-induced dopamine release. Eur J Pharmacol, 1994, 253: 9-1. CrossRef
  27. Zhang Y, Butelman ER, Schlussman SD, / et al. Effect of the endogenous kappa opioid agonist dynorphin A (1-7) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology, 2004, 172: 422-29. CrossRef
  28. Carta AR, Pinna A, Cauli O, / et al. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats. Synapse, 2002, 44: 166-74. CrossRef
  29. Carta AR, Fenu S, Pala P, / et al. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Eur J Neurosci, 2003, 18: 2563-572. CrossRef
  30. Takeba Y, Suzuki N, Kaneko A, / et al. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol, 2001, 28: 2176-183.
  31. Svensson P, Hurd YL. Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence. Brain Res Mol Brain Res, 1998, 56: 162-68. CrossRef
  
• 作者单位：Miaoxian Dong (1)
  Chengchong Li (1)
  Yutao Gen (1)
  Chun Zhang (1)
  Xiaoming Li (1)
  Yingcai Niu (1) (2)
  
  1. Institute of Medicine, Qiqihaer Medical College, Qiqihaer, 161042, China
  2. ITCWM Post-doctor Research Center in Heilongjiang University of Chinese Medicine, Harbin, 150040, China
  

文摘

Objective The aim of the study was to observe the effect of total isoflavones from pueraria lobata (TIP) on D2 dopamine receptor mRNA, preproenkephalin mRNA and prodynorphin mRNA expressions in Parkinson’s disease (PD) model cells induced by 1-methyl-4-phenylpyridinium ion (MPP+). Methods TIP was dissolved in 0.1 M NaOH and added to the culture medium at a final concentrations of 50 mg/L, 100 mg/L and 200 mg/L. Some cells (control) were exposed to 0.001 M NaOH. TIP was added to PC12 cells 30 min prior to the administration of MPP+. TIP and MPP+ remained in the culture medium for 96 h. D2 dopamine receptor mRNA, preproenkephalin mRNA and prodynorphin mRNA expressions were assayed by real-time quantitative reverse transcription-PCR. Results The D2 dopamine receptor mRNA and preproenkephalin mRNA expressions were up-regulated in MPP+ group compared with the control group, and prodynorphin mRNA expression was down-regulated in that. The D2 dopamine receptor mRNA expression being down-regulated and prodynorphin mRNA expression being up-regulated in TIP group compared with the MPP+ group. And there was no effect of TIP on preproenkephalin gene expression in PC12 cells induced by MPP+. Conclusion The results suggest that TIP down-regulates the D2 dopamine receptor mRNA expression, up-regulates prodynorphin mRNA expression and not affects preproenkephalin gene expression in PC12 cells induced by MPP+.